CVS Caremark‘s stock had its “overweight” rating restated by equities researchers at JPMorgan Chase in a report issued on Friday. They currently have a $59.00 target price on the stock.
Shares of CVS Caremark traded up 0.08% during mid-day trading on Friday, hitting $49.82. CVS Caremark has a 52 week low of $41.21 and a 52 week high of $49.80. The stock’s 50-day moving average is currently $47.23. The company has a market cap of $62.110 billion and a P/E ratio of 16.91.
CVS Caremark last issued its quarterly earnings data on Tuesday, November 6th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.84 by $0.01. The company had revenue of $30.23 billion for the quarter, compared to the consensus estimate of $30.09 billion. During the same quarter in 2012, the company posted $0.70 earnings per share. CVS Caremark’s revenue was up 13.3% compared to the same quarter last year. CVS Caremark has set its FY12 guidance at $3.38-3.41 EPS. Analysts expect that CVS Caremark will post $3.40 EPS for the current fiscal year.